Greenwoods Asset Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Greenwoods Asset Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-57,800	Closed	-$6.24M	–	47
2020 Q1	$6.24M	Hold	57,800	–	–	0.28%	19
2019 Q4	$6.73M	Sell	57,800 -181,990	-76%	-$21.1M	0.36%	14
2019 Q3	$27.4M	Sell	239,790 -239,790	-50%	-$23.8M	1.7%	10
2019 Q2	$45.7M	Hold	479,580	–	–	3.02%	8
2019 Q1	$43.8M	Buy	479,580 +353,980	+282%	+$29M	2.69%	6
2018 Q4	$9.53M	Sell	125,600 -119,400	-49%	-$8.79M	0.9%	10
2018 Q3	$19.6M	Buy	+245,000	New	+$22.8M	1.91%	6
2017 Q4	–	Sell	-16,500	Closed	-$1.52M	–	26
2017 Q3	$1.52M	Hold	16,500	–	–	0.13%	20
2017 Q2	$1.87M	Hold	16,500	–	–	0.22%	16
2017 Q1	$1.65M	Hold	16,500	–	–	0.18%	18
2016 Q4	$1.77M	Hold	16,500	–	–	0.21%	18
2016 Q3	$2.05M	Buy	+16,500	New	+$1.95M	0.18%	20

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Greenwoods Asset Management's CBPO Position: Q2 2020 in Review

Greenwoods Asset Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2020, closing a stake of 57,800 shares — an estimated $6.24M sold.

Greenwoods Asset Management first reported a position in CBPO in Q3 2016 and held it in 12 quarters. The position peaked at $45.7M in Q2 2019. 91 funds tracked by Wall St. Rank hold CBPO as of Q2 2020.

Greenwoods Asset Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2020 after selling out during the quarter.
Greenwoods Asset Management sold 57,800 China Biologic Products Holdings, Inc. shares in Q2 2020, an estimated $6.24M.
Greenwoods Asset Management first reported a position in China Biologic Products Holdings, Inc. in Q3 2016 and held it in 12 quarters.
Greenwoods Asset Management's China Biologic Products Holdings, Inc. position peaked at $45.7M in Q2 2019.
91 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2020.

Based on Greenwoods Asset Management's 13F filing for Q2 2020, filed 12 Aug 2020.